empty

Pancreatic cancer survival rate more than doubles

The five-year pancreatic cancer survival rate in the UK has increased from three per cent to a record high of 7.9 per cent since 2010, according to new statistics published in the journal Lancet Oncology

Early diagnosis is considered to be the key factor influencing survival rates. It is thought that efforts to raise awareness of the disease among the public and health professionals is helping more cases to be diagnosed earlier, and so driving the increase in the number of people living five years or longer after their initial diagnosis. 

However, pancreatic cancer still has the lowest survival rate of all major cancers and the UK continues to fall behind other high-income countries.

For example, the five-year survival rate in Australia is almost 15 per cent. 

Although pancreatic cancer is soon to overtake breast cancer as the fourth biggest cancer killer in the UK, the disease currently receives less than three per cent of Government cancer funding.

Becky Rice, health and policy manager at UK charity Pancreatic Cancer Action (PCA), commented: “We must continue to raise awareness of the disease, push for pancreatic cancer-specific policies to improve survival and keep the disease high on the agendas of researchers and policy makers.”

Top Stories

Pharmacy teams urged to make Yellow Card reports

Deadline for CBD companies to keep products on shelves



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Network News's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.